PT806206E - Composicoes aquosas que contem ciprofloxacina e utilizacao e processo correspondentes - Google Patents

Composicoes aquosas que contem ciprofloxacina e utilizacao e processo correspondentes

Info

Publication number
PT806206E
PT806206E PT96924896T PT96924896T PT806206E PT 806206 E PT806206 E PT 806206E PT 96924896 T PT96924896 T PT 96924896T PT 96924896 T PT96924896 T PT 96924896T PT 806206 E PT806206 E PT 806206E
Authority
PT
Portugal
Prior art keywords
compositions containing
aquus
corresponding utilization
containing ciprofloxacin
ciprofloxacine
Prior art date
Application number
PT96924896T
Other languages
English (en)
Inventor
Pedro Canovas Soler
Joaquin Delgadillo Duarte
Juan Moreno Rueda
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Publication of PT806206E publication Critical patent/PT806206E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT96924896T 1995-08-03 1996-07-26 Composicoes aquosas que contem ciprofloxacina e utilizacao e processo correspondentes PT806206E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09501578A ES2106680B1 (es) 1995-08-03 1995-08-03 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.

Publications (1)

Publication Number Publication Date
PT806206E true PT806206E (pt) 2004-01-30

Family

ID=8291281

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96924896T PT806206E (pt) 1995-08-03 1996-07-26 Composicoes aquosas que contem ciprofloxacina e utilizacao e processo correspondentes

Country Status (12)

Country Link
US (1) US5786363A (pt)
EP (1) EP0806206B1 (pt)
JP (1) JP4081521B2 (pt)
AT (1) ATE247962T1 (pt)
AU (1) AU701697B2 (pt)
CA (1) CA2200760C (pt)
DE (1) DE69629664T2 (pt)
DK (1) DK0806206T3 (pt)
ES (2) ES2106680B1 (pt)
PT (1) PT806206E (pt)
RU (1) RU2165755C2 (pt)
WO (1) WO1997005880A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160090B1 (es) * 2000-03-16 2002-07-01 Vita Invest Sa Composiciones acuosas de ciprofloxacino, contenidas en envases monodosis y su utilizacion.
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
KR101367479B1 (ko) * 2008-07-21 2014-03-14 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 귀 질병 치료를 위한 제어 방출형 항미생물성 조성물 및 방법
DK2366408T3 (da) * 2010-03-01 2012-10-22 Salvat Lab Sa Vandige, klare opløsninger af fluocinolonacetonid til behandling af inflammation i øret
EP3512513A4 (en) 2016-09-16 2020-04-15 Otonomy, Inc. GEL FORMULA FOR THE EAR FOR TREATING OTITIS EXTERNA
CN112986468B (zh) * 2019-12-13 2024-05-03 武汉九州钰民医药科技有限公司 检测盐酸环丙沙星片中氯代环丙沙星的分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3632222A1 (de) * 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren
ES2111083T3 (es) * 1991-09-17 1998-03-01 Alcon Lab Inc Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno).
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
JPH11500740A (ja) 1999-01-19
ES2106680B1 (es) 1998-07-01
EP0806206A1 (en) 1997-11-12
RU2165755C2 (ru) 2001-04-27
AU6520196A (en) 1997-03-05
DK0806206T3 (da) 2003-12-08
ES2106680A1 (es) 1997-11-01
CA2200760A1 (en) 1997-02-20
EP0806206B1 (en) 2003-08-27
JP4081521B2 (ja) 2008-04-30
DE69629664T2 (de) 2004-06-24
WO1997005880A1 (es) 1997-02-20
ATE247962T1 (de) 2003-09-15
DE69629664D1 (de) 2003-10-02
ES2205048T3 (es) 2004-05-01
CA2200760C (en) 2007-09-11
AU701697B2 (en) 1999-02-04
US5786363A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
CO4750807A1 (es) Solucion de interferon
ES2183023T3 (es) Composicion farmaceutica estabilizada con un agente basico.
ES2113652T3 (es) Pamoato de risperidona.
ES2085652T3 (es) Soluciones estabilizadas de peracido.
YU47204B (sh) Derivati didehidro-vitamina d3
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
FI971486A0 (fi) Alfa-interferonin stabiilit vesiliuosformulaatiot
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
FI932601A (fi) Mattrengoeringsmedel
DE58905235D1 (de) Wasch- und reinigungsmittel.
PT788480E (pt) Cristalizacao de levobupivacaina e seus analogos
PT806206E (pt) Composicoes aquosas que contem ciprofloxacina e utilizacao e processo correspondentes
ES2146606T3 (es) Metodo para limpiar alfombras.
ATE190498T1 (de) Stabile, pharmazeutische zusammensetzungen die hybrid alpha-interferon enthalten
BG103306A (en) Liquid allendronate compositions
ES2174481T3 (es) Empleo de soluciones que contienen enzimas para la limpieza de tanques de fermentacion o de almacenamiento.
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
ATE179208T1 (de) Wässrige handgeschirrspülmittel
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
SE9302201D0 (sv) Composition for ophthalmic use